The Asia Pacific Urology Laser Market would witness market growth of 7.0% CAGR during the forecast period (2023-2031).
The China market dominated the Asia Pacific Urology Laser Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $140.8 million by 2031. The Japan market is registering a CAGR of 6.4% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.7% during (2024 - 2031).
The integration of urology lasers with advanced imaging technologies has also contributed to their expanded use. Real-time imaging allows surgeons to visualize the treatment area more clearly, enabling them to perform procedures more accurately and safely. This integration has opened up new possibilities for minimally invasive procedures that were not previously feasible with conventional surgical techniques.
The expanding applications of urology lasers are reshaping the landscape of urological care, offering innovative solutions for various conditions beyond their traditional uses. One notable application is the treatment of bladder tumours, where these are increasingly utilized for their precision and efficacy. Laser ablation or vaporization can target and remove tumor tissue with minimal damage to surrounding healthy tissue, offering a less invasive alternative to traditional surgery.
The Asia-Pacific region is witnessing an expanding market, driven by the increasing incidence of bladder cancer and kidney stones in several countries. According to the National Library of Medicine (NLM), Singapore, Indonesia, Thailand, and Malaysia have reported varying incidence rates of bladder cancer, with Singapore recording the highest rate of 2.7 per 100,000 population. Hence, the expanding market in the Asia-Pacific region is fuelled by the increasing incidence of bladder cancer and kidney stones in countries like Singapore, Indonesia, Thailand, Malaysia, China, and India.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium Laser System, Diode Laser System, and Others. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC), and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Urology Laser Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $140.8 million by 2031. The Japan market is registering a CAGR of 6.4% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.7% during (2024 - 2031).
The integration of urology lasers with advanced imaging technologies has also contributed to their expanded use. Real-time imaging allows surgeons to visualize the treatment area more clearly, enabling them to perform procedures more accurately and safely. This integration has opened up new possibilities for minimally invasive procedures that were not previously feasible with conventional surgical techniques.
The expanding applications of urology lasers are reshaping the landscape of urological care, offering innovative solutions for various conditions beyond their traditional uses. One notable application is the treatment of bladder tumours, where these are increasingly utilized for their precision and efficacy. Laser ablation or vaporization can target and remove tumor tissue with minimal damage to surrounding healthy tissue, offering a less invasive alternative to traditional surgery.
The Asia-Pacific region is witnessing an expanding market, driven by the increasing incidence of bladder cancer and kidney stones in several countries. According to the National Library of Medicine (NLM), Singapore, Indonesia, Thailand, and Malaysia have reported varying incidence rates of bladder cancer, with Singapore recording the highest rate of 2.7 per 100,000 population. Hence, the expanding market in the Asia-Pacific region is fuelled by the increasing incidence of bladder cancer and kidney stones in countries like Singapore, Indonesia, Thailand, Malaysia, China, and India.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium Laser System, Diode Laser System, and Others. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC), and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Olympus Corporation
- Biolitec AG
- Stryker Corporation
- Boston Scientific Corporation
- Richard Wolf GmbH
- Cook Medical, Inc.(Cook Group)
- Karl Storz SE & Co. KG
- OmniGuide, Inc.
- Allengers Medical Systems Ltd.
- Becton, Dickinson and Company
Market Report Segmentation
By Laser Type- Holmium Laser System
- Thulium Laser System
- Diode Laser System
- Others
- Benign Prostatic Hyperplasia (BPH)
- Urolithiasis
- Non-Muscle-Invasive Bladder Cancer (NMIBC)
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Urology Laser Market by Laser Type
Chapter 5. Asia Pacific Urology Laser Market by Application
Chapter 6. Asia Pacific Urology Laser Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Olympus Corporation
- Biolitec AG
- Stryker Corporation
- Boston Scientific Corporation
- Richard Wolf GmbH
- Cook Medical, Inc.(Cook Group)
- Karl Storz SE & Co. KG
- OmniGuide, Inc.
- Allengers Medical Systems Ltd.
- Becton, Dickinson and Company
Methodology
LOADING...
